Prognostic Implication of Diagnostic Confidence Level in Patients with Fibrotic Hypersensitivity Pneumonitis

被引:6
|
作者
Kang, Jieun [1 ,2 ]
Kim, Yeon Joo [1 ]
Choe, Jooae [3 ]
Chae, Eun Jin [3 ]
Song, Joon Seon [4 ]
Song, Jin Woo [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea
[2] Inje Univ, Coll Med, Ilsan Paik Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Goyang, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Hypersensitivity pneumonitis; Mortality; Prediction; Prognosis; IDIOPATHIC PULMONARY-FIBROSIS; PREDICTS SURVIVAL; LUNG-DISEASE; STANDARDIZATION; CLASSIFICATION;
D O I
10.1159/000517921
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Hypersensitivity pneumonitis (HP) has various clinical courses and outcomes, but the prognostic factors are not well-defined. Vasakova et al. [Am J Respir Crit Care Med. 2017 Sep;196(6):680-9] have proposed a diagnostic algorithm that categorized suspected patients according to the level of confidence in the diagnosis. This study aimed to investigate whether the confidence level of clinical diagnosis has prognostic implication in patients with fibrotic HP. Methods: This study included 101 biopsy-proven fibrotic HP patients diagnosed between 2002 and 2017. The patients were retrospectively classified into confident, probable, possible, and unlikely chronic HP, according to the confidence level in the diagnostic criteria/algorithm. The survival and forced vital capacity (FVC) changes were compared between the groups. Risk factors for mortality were analysed using a Cox proportional hazard model. Results: The median follow-up duration was 67.6 months. The mean age was 60.4 years, and percentages of women were 60.4%. When classified based on the diagnostic criteria/algorithm, possible HP was the most common (51.5%), followed by probable (26.7%), confident (9.9%), and unlikely HP (6.9%). Distinctive survival curves were found according to the diagnostic confidence level, showing the worst outcome in unlikely chronic HP (median survival, 30.2 months). In a multivariable Cox analysis, unlikely HP was a significant predictor of poor survival (hazard ratio, 4.652; 95% confidence interval, 1.231-17.586; p = 0.023), after adjustment for age, body mass index, FVC, and diffusing capacity. Conclusions: The diagnostic confidence level may predict clinical outcomes in patients with HP. Unlikely HP was shown to have a significantly poorer survival than other diagnostic confidence levels.
引用
收藏
页码:940 / 948
页数:9
相关论文
共 50 条
  • [1] Diagnostic Confidence and Prognosis in Fibrotic Hypersensitivity Pneumonitis: Classification Is Fundamental
    Tzilas, Vasilios
    Bouros, Demosthenes
    RESPIRATION, 2021, 100 (10) : 937 - 939
  • [2] Fibrotic hypersensitivity pneumonitis
    Fernandez Perez, Evans R.
    Brown, Kevin K.
    CURRENT PULMONOLOGY REPORTS, 2014, 3 (04) : 170 - 178
  • [3] Fibrotic hypersensitivity pneumonitis
    Evans R. Fernández Pérez
    Kevin K. Brown
    Current Respiratory Care Reports, 2014, 3 (4): : 170 - 178
  • [4] Management of fibrotic hypersensitivity pneumonitis
    Mullin, Monica L.
    Churg, Andrew
    Ryerson, Christopher J.
    CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (05) : 421 - 431
  • [5] Management of Fibrotic Hypersensitivity Pneumonitis
    Barnes, Hayley
    Johannson, Kerri A.
    CLINICS IN CHEST MEDICINE, 2021, 42 (02) : 311 - 319
  • [6] Potential biomarkers for the diagnosis of patients with fibrotic hypersensitivity pneumonitis
    Sanchez-Diez, Silvia
    Munoz, Xavier
    Espejo, David
    Gomez-Olles, Susana
    Ojanguren, Inigo
    Romero-Mesones, Christian
    Cruz, Maria-Jesus
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [7] Telomere Shortening in Patients With Familial Fibrotic Hypersensitivity Pneumonitis
    Nishimura, M.
    Kitamura, H.
    Tagami, Y.
    Fujimoto, K.
    Otoshi, R.
    Niwa, T.
    Baba, T.
    Okudera, K.
    Iwasawa, T.
    Itou, K.
    Natsume, Y.
    Ogura, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [8] Effects of immunosuppressants in patients with mild fibrotic hypersensitivity pneumonitis
    Okuda, Ryo
    Takemura, Tamiko
    Misumi, Toshihiro
    Komatsu, Shigeru
    Hagiwara, Eri
    Ogura, Takashi
    RESPIRATORY INVESTIGATION, 2025, 63 (01) : 13 - 19
  • [9] PROGNOSTIC VALUE OF ROUTINE PERIPHERAL BLOOD MARKERS IN FIBROTIC HYPERSENSITIVITY PNEUMONITIS
    Stock, C. J. W.
    Bray, W.
    Kokosi, M.
    Kouranos, V.
    George, P. M.
    Molyneaux, P. L.
    Chua, F.
    Jenkins, G. R.
    Wells, A. U.
    Renzoni, E. A.
    THORAX, 2022, 77 : A95 - A95
  • [10] Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management
    Francesco Varone
    Bruno Iovene
    Giacomo Sgalla
    Mariarosaria Calvello
    Angelo Calabrese
    Anna Rita Larici
    Luca Richeldi
    Lung, 2020, 198 : 429 - 440